Actionable insights straight to your inbox

Equities logo

OncoSec (ONCS) Announces Positive Updated Long-Term Follow-Up Data from Phase 2 Trial of ImmunoPulse

OncoSec Medical Incorporated (NASDAQ:ONCS) today announced positive updated long-term follow-up data from its Phase 2 OMS I-102
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.